company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-159000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-159000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2790000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,480000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2552000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4954000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,709000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,709000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4351000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-15000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-712000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5078000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5078000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-15577000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-15000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,16000000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-49000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,359000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,359000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4010000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,238000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3942000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1829000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1829000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2984000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,477000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1846000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1376000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,8512000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,8512000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3746000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,43000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,534000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3169000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3169000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-16701000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,15000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,15000000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,55000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-2069000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3700000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3700000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1643000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,255000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q4,2013-10-01,2013-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,141000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1619000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1619000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2940000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,475000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1781000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9412000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5835000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5835000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4030000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-767000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4797000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4797000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-15673000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,25000000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-147000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9180000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9180000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1452000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,209000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,79000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1180000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1180000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3096000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,481000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2632000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4095000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,934000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,934000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3060000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-18352000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-506000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-21918000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-21918000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-30359000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1920000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,26505000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,38589000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,147000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,32962000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,32962000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-32000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,11946000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,364000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,5000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5379000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5379000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3199000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,481000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2738000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,12591000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,13630000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,13630000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4028000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,898000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3130000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3130000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1117000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-355000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1472000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1472000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-228000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,8800000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,405000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2521000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2521000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3293000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,483000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2777000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,8291000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,12323000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,12323000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9381000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-547000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9928000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9928000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-7065000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-345000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-34000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1109000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-8553000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-8553000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1105000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5053000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1629000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,350000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-665000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-665000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2771000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,481000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2262000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3511000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1338000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1338000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3780000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1265000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5045000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5045000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1193000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1489000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,6789000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,910000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-572000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4445000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4445000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,22000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,760000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,469000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6647000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6647000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2861000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,498000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3789000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2002000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2503000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2503000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2960000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,33000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-792000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3719000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3719000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1331000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1226000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-3000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,9813000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-169000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7084000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7084000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,7000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5875000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,428000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3008000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3008000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2884000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,479000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3486000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-288000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3553000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3553000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3945000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,18000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,225000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3702000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3702000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1449000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2972000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,816000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-116000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3721000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3721000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,88000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3782000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,448000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,45000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,7533000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7533000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2798000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,480000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3588000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-11112000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3287000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3287000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5311000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,-51000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,903000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4459000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4459000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5018000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-4178000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-1000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2769000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,857000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-5571000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-5571000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,2136000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4607000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,596000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,101000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2489000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2489000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2947000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,481000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4105000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3908000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,13930000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,13930000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3946000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-4761000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-713000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9420000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9420000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-6036000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-4722000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3725000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-7033000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-7033000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-219000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2742000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,517000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,367000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6895000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6895000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3048000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,569000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4909000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6095000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,9326000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,9326000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5398000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2608000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8006000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8006000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-378000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-3468000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5808000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1962000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1962000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,46000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3328000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,430000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,186000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3890000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3890000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3014000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,701000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3584000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9891000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1298000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1298000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6701000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-7700000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2270000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1414000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,295000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-14962000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-14962000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3554000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-796000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,665000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,17157000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,13472000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,13472000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,130000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-62000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,434000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2710000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3454000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3454000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3152000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,766000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3768000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,9774000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,14006000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,14006000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5337000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1332000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1661000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2105000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7113000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7113000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4684000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-922000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4345000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1261000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1261000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,124000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5756000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,341000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,134000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,893000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,893000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3100000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,721000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1808000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,15876000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,22398000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,22398000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7267000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1564000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,1000000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1345000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,521000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5965000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5965000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3515000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-8203000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-11718000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-11718000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-174000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4541000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,390000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,440000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1972000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1972000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3135000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,705000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4380000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5618000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4574000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4574000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6301000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,303000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,1000000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,-284000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2544000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7826000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7826000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,897000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-8978000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,11118000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,7278000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,10315000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,10315000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,451000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7514000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,402000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,4129000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3433000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,713000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4434000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6103000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2472000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2472000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-11413000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4384000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2589000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,238000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12970000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12970000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5763000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-7592000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,7865000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-23000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-5513000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-5513000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,387000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-15624000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,542000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,307000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,787000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,787000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3286000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,717000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4128000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,847000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,9765000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,9765000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-10118000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-11000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10129000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10129000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1331000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-5974000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,6503000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-802000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-802000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-160000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1326000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,543000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7141000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7141000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3060000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,729000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5264000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6448000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,8360000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,8360000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12340000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-201000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,4400000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-597000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8738000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8738000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3204000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-7624000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-10828000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-10828000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,159000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11047000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,532000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,8000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2853000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2853000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3453000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,722000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4341000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1130000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4533000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4533000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12251000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,483000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11771000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11771000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,76000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-7226000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,8260000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1110000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1110000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-349000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6477000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,546000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,141000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1616000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1616000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3901000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,271000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3555000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6438000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,15781000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,15781000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12635000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-102000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,91000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-230000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12876000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12876000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1169000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-7590000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,87000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,26476000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,17804000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,17804000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-45000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,20664000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,650000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,14000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1718000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1718000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4115000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,265000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4949000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1530000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,9517000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,9517000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9582000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,245000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,542000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8797000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8797000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1408000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2607000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,431000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,20506000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,16922000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,16922000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-39000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,17603000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,648000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,176000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2154000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2154000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4158000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,974000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5479000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-12067000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3610000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3610000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-14744000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-151000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,11000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-14884000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-14884000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1657000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-3015000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,18298000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-2397000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,11229000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,11229000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,24000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7241000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,898000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,234000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,46920000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,46920000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4153000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,942000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4077000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4369000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,51723000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,51723000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9723000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,151000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-97000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9669000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9669000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2066000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1073000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2397000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-742000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-742000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-35000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,41277000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,379000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,913000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,984000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,984000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4216000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1049000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4313000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-22565000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12003000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12003000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8678000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9825000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-119000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-18622000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-18622000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1443000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-4426000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1981000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3888000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3888000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-249000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-34762000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,597000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3042000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,755000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,755000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4546000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1083000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4462000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5194000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5652000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5652000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8410000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,1010000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,48000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7352000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7352000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1615000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-13777000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3570000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1440000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-10382000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-10382000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,156000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11926000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,561000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1528000.0
